文献速递质量管理与危急值

十个国家外部质量评估表现:IFCC全球实验室质量项目

External quality assessment performance in ten countries: an IFCC global laboratory quality project.
PubMed 文献 · Clin Chem Lab Med · 2024-09-02

IFCC全球实验室质量工作组在2022和2023年向十个成员国的100家实验室提供EQA材料、软件和在线培训,按月分析提交数量、可接受率等。第二年结果显示,十个国家中六个全年平均可接受结果超过90%,一个国家九个月中有两个月不可接受,其余四个未达可接受标准;所有实验室对调查和服务表示满意,但标本接收问题提示应全年12个月分发材料。

要点

  • 十个国家中六个全年平均可接受EQA结果超过90%。
  • 一个国家九个月中有两个月结果不可接受,四个国家未达可接受标准。
  • 所有100家参与实验室对EQA调查及相关服务表示满意。

核心结论

  • 十国EQA表现差异显著,四个国家需要长期援助、培训和指导。
  • 标本接收问题提示全年12个月分发EQA材料可能有益。
  • 所有100家参与实验室对EQA调查及相关服务表示满意。

研究设计与样本

  • IFCC全球实验室质量工作组开展为期2年(2022和2023年)的研究。
  • 由商业供应商向十个IFCC成员学会国家的100家实验室提供EQA材料、相关软件和在线培训。
  • 结果由工作组每月分析,包括每国提交数、每实验室测试数、可接受率、随机失败和表现不佳的分析物。

主要发现

  • EQA材料按季度分发,部分国家海关放行问题导致实验室未按时收到材料而无提交。
  • 各实验室检测分析物数量在7至84之间不等。
  • 十国中六个全年12个月周期平均可接受结果超过90%。
  • 一个国家在返回结果的九个月中有两个月结果不可接受。
  • 其余四个国家被认为未达可接受标准。

关键数值与推荐

  • 六个国家全年12个月周期平均可接受结果超过90%。
  • 一个国家九个月返回结果中有两个月不可接受。
  • 各实验室检测分析物数量范围为7至84个。

临床怎么用

  • 需关注EQA材料及时接收问题,考虑全年12个月分发材料。
  • 对EQA表现未达可接受标准的国家应提供长期援助、培训和指导。
  • 在特定国家推广EQA以确保患者结果可靠并达到所需质量水平。

局限性

  • 部分国家因海关放行问题导致实验室未按时收到EQA材料而无提交。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to assess the validity of external quality assessment (EQA) laboratory results across various cultural and environmental contexts and to identify potential improvement areas. METHODS: The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Task Force on Global Laboratory Quality (TF-GLQ) conducted a 2-year study (2022 and 2023) in which EQA materials, related software and online training was provided by a commercial vendor to 100 laboratories in ten IFCC member society countries. The results were analysed on a monthly basis by the TF-GLQ, to show the number of submissions per country, tests per lab, acceptability rates, random failures and to get a measure of which analytes performed poorly. RESULTS: The EQA material was dispatched on a quarterly basis. Some countries had problems with customs releasing the material in a timely manner, resulting in laboratories not receiving them on time leading to no submission. We report here the results for the second year of the survey. The number of examinations varied between laboratories, ranging from seven to 84 analytes. Of the ten countries surveyed, six averaged greater than 90 % acceptable results over the whole 12-months cycle, one had unacceptable results for two of the nine months they returned results and the other four were considered to not perform to an acceptable standard. CONCLUSIONS: All 100 participating laboratories indicated satisfaction with the EQA survey and related services, including on-site training, and report handling. However, specimen receiving issues, suggest benefits in dispatching materials for a full 12-month cycle. Significant discrepancies in EQA performance indicate that four countries require long-term assistance, training and guidance. To ensure reliable patient results, promoting EQA in certain countries is essential to achieve the required level of quality.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Bais R, Vassault A, Blasutig IM, et al. External quality assessment performance in ten countries: an IFCC global laboratory quality project. Clin Chem Lab Med. 2024. PMID: 39238208. doi:10.1515/cclm-2024-0859

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。